Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
Clinical trial NCT03137784 · COMPLETED
Trial details
- NCT number
- NCT03137784
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2017-12-29
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.